A Follow-Up Clinical Trial Evaluating the Consumer-Decides Service Delivery Model.

Am J Audiol · 2019 · PMC6802858 · PMID 30938563

Europe PMC DOI

hedged sentence

0.0850

closest p · 1.7× alpha

0.0850

boldest claim

The sentences

approached significancep = .085so close (0.05 < p ≤ 0.1)

There were no significant differences in the performance of the CD2-CD and CD2-P subgroups on the other three outcome measures in Figure 8 , although the difference in CST benefit approached significance ( p = .085).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.